RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
26 hedge funds and large institutions have $14.2M invested in Regulus Therapeutics in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 2 closing their positions.
Holders
26
Holders Change
+1
Holders Change %
+4%
% of All Funds
0.38%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
3
Increased
6
Reduced
4
Closed
2
Calls
$458K
Puts
$3K
Net Calls
+$455K
Net Calls Change
-$80K
Top Buyers
1 |
EAM
1
Exome Asset Management
New York
|
$228K |
2 |
2
Victory Capital Management
San Antonio,
Texas
|
$348K |
3 |
3
Citadel Advisors
Miami,
Florida
|
$36.4K |
4 |
4
Renaissance Technologies
New York
|
$70K |
5 |
5
Citigroup
New York
|
$2.72K |